Neuroscientist Gary Gibson, Ph.D. ’73, keeps a framed picture of a cell derived from the skin cells of a person with Alzheimer’s disease on his office wall.
The image is a memento of Gibson’s breakthrough…
A multicenter randomized, controlled clinical trial aims to test whether a minimally invasive treatment can relieve chronic pelvic pain and improve the quality of life for women with pelvic venous disease.
Two friends who bonded over shared concerns over their bone health have formulated a bioavailable calcium chew using milk protein from Finger Lakes dairy farms.
Reinforcement Learning, an artificial intelligence approach, has the potential to guide physicians in designing sequential treatment strategies for better patient outcomes but requires significant improvements before it can be applied in clinical settings.
Turning aquatic vegetation near agricultural land into compost simultaneously eradicates habitat for disease-carrying snails while improving agricultural output and increasing incomes in northern Senegal, Cornell researchers have found.
Cornell researchers built miniature VR headsets to immerse mice more deeply in virtual environments that can help reveal the neural activity that informs spatial navigation and memory function and generate new insights into disorders such as Alzheimer’s disease and its potential treatments.
Prostate cancer hijacks the normal prostate’s growth regulation program to release the brakes and grow freely, according to Weill Cornell Medicine researchers.
A newer hepatitis B vaccine was superior to an older type in inducing a protective antibody response among people living with HIV who didn’t respond to prior vaccination, according to a study led by a Weill Cornell Medicine investigator.
